Figure 3

Upper row: effects of selected peptides on the viability of HeLa, HaCaT and HepG2 cells. Lower row; dose–response behavior of compounds 11 and 18 illustration differences in cellular response.
Upper row: effects of selected peptides on the viability of HeLa, HaCaT and HepG2 cells. Lower row; dose–response behavior of compounds 11 and 18 illustration differences in cellular response.